Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-making.

导出 LinkOut

翻译打印收藏纠错

作者： Daqiang,Sun ^[1] ; Meilin,Xu ^[2] ; Chaohu,Pan ^[3] ; Hongzhen,Tang ^[4] ; Peng,Wang ^[4] ; Dongfang,Wu ^[4] ; Haitao,Luo ^[4]

作者单位： Department of Thoracic Surgery, Tianjin Chest Hospital, Affiliated Chest Hospital of Tianjin University, Tianjin, China. ^[1] Pathology Department, Tianjin Chest Hospital, Affiliated Chest Hospital of Tianjin University, Tianjin, China. ^[2] The First Affiliated Hospital, Jinan University, Guangzhou, China. ^[3] Department of Medicine, YuceBio Technology Co., Ltd, Shenzhen, China. ^[4]

关键词 East Asian populations clinical decision-making immunotherapy method optimizing tumor mutation burden

DOI 10.3389/fonc.2022.972972

PMID 36425562

发布时间 2022-11-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

972972页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-making.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-making.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除